200,000+ products from a single source!
sales@angenechem.com
Home > Sulfanilamide > 40182-06-7
40182-06-7 | 2-phenylbenzene-1-sulfonamide
CAS No: 40182-06-7 Catalog No: AG01A7ZX MDL No:MFCD11650103
Product Description
Catalog Number:
AG01A7ZX
Chemical Name:
2-phenylbenzene-1-sulfonamide
CAS Number:
40182-06-7
Molecular Formula:
C12H11NO2S
Molecular Weight:
233.2862
MDL Number:
MFCD11650103
IUPAC Name:
2-phenylbenzenesulfonamide
InChI:
InChI=1S/C12H11NO2S/c13-16(14,15)12-9-5-4-8-11(12)10-6-2-1-3-7-10/h1-9H,(H2,13,14,15)
InChI Key:
SBXDENYROQKXBE-UHFFFAOYSA-N
SMILES:
NS(=O)(=O)c1ccccc1c1ccccc1
Properties
Complexity:
314
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
233.051g/mol
Formal Charge:
0
Heavy Atom Count:
16
Hydrogen Bond Acceptor Count:
3
Hydrogen Bond Donor Count:
1
Isotope Atom Count:
0
Molecular Weight:
233.285g/mol
Monoisotopic Mass:
233.051g/mol
Rotatable Bond Count:
2
Topological Polar Surface Area:
68.5A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
2.1
Literature
| Title | Journal |
|---|---|
| Serum albumin targeted, pH-dependent magnetic resonance relaxation agents. | Chemistry (Weinheim an der Bergstrasse, Germany) 20120319 |
| Identification of biaryl sulfone derivatives as antagonists of the histamine H₃ receptor: discovery of (R)-1-(2-(4'-(3-methoxypropylsulfonyl)biphenyl-4-yl)ethyl)-2-methylpyrrolidine (APD916). | Bioorganic & medicinal chemistry letters 20120101 |
| Stroma targeting nuclear imaging and radiopharmaceuticals. | International journal of molecular imaging 20120101 |
| Continued exploration of biphenylsulfonamide scaffold as a platform for aggrecanase-1 inhibition. | Bioorganic & medicinal chemistry letters 20111115 |
| Design and evaluation of novel biphenyl sulfonamide derivatives with potent histamine H(3) receptor inverse agonist activity. | Journal of medicinal chemistry 20090924 |
| Structure-based drug design of pyrrolidine-1, 2-dicarboxamides as a novel series of orally bioavailable factor Xa inhibitors. | Chemical biology & drug design 20070601 |
| alpha-Biphenylsulfonylamino 2-methylpropyl phosphonates: enantioselective synthesis and selective inhibition of MMPs. | Bioorganic & medicinal chemistry 20070115 |
| Development and characterization of biphenylsulfonamides as novel inhibitors of bone resorption. | Journal of medicinal chemistry 20061214 |
| Tryptophane-based biphenylsulfonamide matrix metalloproteinase inhibitors as tumor imaging agents. | Cancer biotherapy & radiopharmaceuticals 20051201 |
| Novel cyclopentane dicarboxamide sodium channel blockers as a potential treatment for chronic pain. | Bioorganic & medicinal chemistry letters 20050401 |
| New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2). | Bioorganic & medicinal chemistry 20040501 |
| Synthesis of radiolabeled biphenylsulfonamide matrix metalloproteinase inhibitors as new potential PET cancer imaging agents. | Bioorganic & medicinal chemistry letters 20030707 |
Related Products
Featured Products
© 2019 Angene International Limited. All rights Reserved.